Copia Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$221 Hold
10
– – ﹤0.01% 566
2026
Q2
$205 Hold
10
– – ﹤0.01% 549
2026
Q1
$159 Hold
10
– – ﹤0.01% 516
2025
Q4
$263 Hold
10
– – ﹤0.01% 507
2025
Q3
$226 Hold
10
– – ﹤0.01% 463
2025
Q2
$199 Hold
10
– – ﹤0.01% 455
2025
Q1
$169 Hold
10
– – ﹤0.01% 439
2024
Q4
$185 Buy
+10
New +$195 ﹤0.01% 412

Other funds holding FLGT

Copia Wealth Management's FLGT Position: Q3 2026 in Review

Copia Wealth Management held its Fulgent Genetics (FLGT) position steady in Q3 2026 at 10 shares worth $221. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Copia Wealth Management first reported a position in FLGT in Q4 2024 and has held it in 8 quarters since. The position peaked at $263 in Q4 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • Copia Wealth Management held 10 shares of Fulgent Genetics worth $221 as of Q3 2026.
  • Copia Wealth Management left its Fulgent Genetics share count unchanged in Q3 2026.
  • Fulgent Genetics made up ﹤0.01% of Copia Wealth Management's portfolio in Q3 2026, its #566 holding.
  • Copia Wealth Management first reported a position in Fulgent Genetics in Q4 2024 and has held it in 8 quarters since.
  • Copia Wealth Management's Fulgent Genetics position peaked at $263 in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on Copia Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.